119 related articles for article (PubMed ID: 9570351)
1. Serum ceruloplasmin as a diagnostic marker of cancer.
Senra Varela A; Lopez Saez JJ; Quintela Senra D
Cancer Lett; 1997 Dec; 121(2):139-45. PubMed ID: 9570351
[TBL] [Abstract][Full Text] [Related]
2. Serum ceruloplasmin in melanoma patients.
Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
Anticancer Res; 2001; 21(1B):629-32. PubMed ID: 11299817
[TBL] [Abstract][Full Text] [Related]
3. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Br J Cancer; 1993 Apr; 67(4):852-5. PubMed ID: 8471445
[TBL] [Abstract][Full Text] [Related]
4. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
Merle U; Eisenbach C; Weiss KH; Tuma S; Stremmel W
J Hepatol; 2009 Nov; 51(5):925-30. PubMed ID: 19720421
[TBL] [Abstract][Full Text] [Related]
5. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
6. Urinary 24-hour copper excretion at the time of diagnosis in children with Wilson's disease.
Aksu AÜ; Sarı S; Gürkan ÖE; Dalgıç B
Acta Gastroenterol Belg; 2018; 81(3):410-414. PubMed ID: 30350530
[TBL] [Abstract][Full Text] [Related]
7. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
8. Copper and ceruloplasmin levels in serum of women with breast cancer.
Vaidya SM; Kamalakar PL
Indian J Med Sci; 1998 May; 52(5):184-7. PubMed ID: 9808908
[TBL] [Abstract][Full Text] [Related]
9. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
10. CA 15-3, ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer.
Ozyilkan O; Baltali E; Kirazli S
East Afr Med J; 2000 Jun; 77(6):291-4. PubMed ID: 12858925
[TBL] [Abstract][Full Text] [Related]
11. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer.
Nagy B; Bhattoa HP; Steiber Z; Csobán M; Szilasi M; Méhes G; Müller M; Lázár J; Kappelmayer J; Antal-Szalmás P
Clin Chem Lab Med; 2014 Nov; 52(11):1639-48. PubMed ID: 24829194
[TBL] [Abstract][Full Text] [Related]
12. Serum ceruloplasmin as a marker in prostate cancer.
Fotiou K; Vaiopoulos G; Lilakos K; Giannopoulos A; Mandalenaki K; Marinos G; Koritsiadis G; Sourdis J; Konstantinidou E; Konstantopoulos K
Minerva Urol Nefrol; 2007 Dec; 59(4):407-11. PubMed ID: 17947957
[TBL] [Abstract][Full Text] [Related]
13. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma.
Deichmann M; Benner A; Bock M; Jäckel A; Uhl K; Waldmann V; Näher H
J Clin Oncol; 1999 Jun; 17(6):1891-6. PubMed ID: 10561230
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.
Wu X; Li D; Liu L; Liu B; Liang H; Yang B
Arch Gynecol Obstet; 2014 Jun; 289(6):1309-14. PubMed ID: 24370956
[TBL] [Abstract][Full Text] [Related]
15. DR-70 as a novel diagnostic biomarker for gastric cancer.
Arhan M; Yılmaz H; Önal İK; Kocabıyık M; Erdal H; İbiş M
Turk J Gastroenterol; 2015 Nov; 26(6):480-3. PubMed ID: 26575041
[TBL] [Abstract][Full Text] [Related]
16. Ceruloplasmin level in women with breast disease. Preliminary results.
Ozyilkan O; Baltali E; Ozyilkan E; Tekuzman G; Kars A; Firat D
Acta Oncol; 1992; 31(8):843-6. PubMed ID: 1290632
[TBL] [Abstract][Full Text] [Related]
17. Serum copper and ceruloplasmin concentrations in patients with primary breast cancer.
Yenisey C; Fadiloğlu M; Onvural B
Biochem Soc Trans; 1996 May; 24(2):321S. PubMed ID: 8736979
[No Abstract] [Full Text] [Related]
18. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
19. Assessing the diagnostic value of serum Dickkopf-related protein 1 levels in cancer detection: a case-control study and meta-analysis.
Jiang XT; Ma YY; Guo K; Xia YJ; Wang HJ; Li L; He XJ; Huang DS; Tao HQ
Asian Pac J Cancer Prev; 2014; 15(21):9077-83. PubMed ID: 25422182
[TBL] [Abstract][Full Text] [Related]
20. Utility of plasmatic levels of alpha-1-antiprotease (A1AP) as a cancer marker.
Varela AS; López Sáez JJ
Cancer Lett; 1995 Feb; 89(1):15-21. PubMed ID: 7882297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
